EMEA-002157-PIP01-17

Key facts

Active substance
Recombinant Hepatitis B vaccine
Therapeutic area
Vaccines
Decision number
P/0342/2019
PIP number
EMEA-002157-PIP01-17
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Prevention of hepatitis B virus infection
Route(s) of administration
Intramuscular use
Contact for public enquiries
VBI Vaccines Inc.

Tel. +1 6137494200 ext.151
E-mail: byassin-rajkumar@vbivaccines.com

Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)

Decision

How useful was this page?

Add your rating
Average
1 rating